<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Osteopontin (OPN), a secreted phosphorylated <z:chebi fb="2" ids="17089">glycoprotein</z:chebi>, has been found to be involved in <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e>, progression and <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> of several types of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>The aim of the present study was to investigate the immunohistochemical expression of OPN in colorectal <z:mp ids='MP_0002038'>carcinoma</z:mp> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) and its relationship with clinicopathological parameters and P53 </plain></SENT>
<SENT sid="2" pm="."><plain>Expression of OPN, Ki-67 and TP53 was detected in 77 cases of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> by immunohistochemistry and the correlation of the expression of OPN with clinicopathological features, Ki-67 and P53 staining was investigated </plain></SENT>
<SENT sid="3" pm="."><plain>Thirty-eight cases (49.4%) of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> demonstrated OPN overexpression </plain></SENT>
<SENT sid="4" pm="."><plain>Overexpression of OPN was associated with lymph node <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> (P=0.025) and Dukes' stages (P=0.031), but not with gender, histological differentiation, depth of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> invasion, TNM stages or Ki-67 index </plain></SENT>
<SENT sid="5" pm="."><plain>The correlation between expression of OPN and TP53 was statistically significant (P=0.030) </plain></SENT>
<SENT sid="6" pm="."><plain>In conclusion, OPN is overexpressed in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>, and plays a role in <z:e sem="disease" ids="C0178874" disease_type="Neoplastic Process" abbrv="">tumor progression</z:e> and <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e>, which is possibly regulated by P53 </plain></SENT>
</text></document>